Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7UVF

Crystal structure of ZED8 Fab complex with CD8 alpha

Summary for 7UVF
Entry DOI10.2210/pdb7uvf/pdb
DescriptorT-cell surface glycoprotein CD8 alpha chain, Immunoglobulin heavy chain, Immunoglobulin light chain, ... (6 entities in total)
Functional Keywordsimaging, cd8, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains6
Total formula weight122837.79
Authors
Yu, C.,Davies, C.,Koerber, J.T.,Williams, S. (deposition date: 2022-05-01, release date: 2022-10-12, Last modification date: 2024-11-06)
Primary citationOgasawara, A.,Kiefer, J.R.,Gill, H.,Chiang, E.,Sriraman, S.,Ferl, G.Z.,Ziai, J.,Bohorquez, S.S.,Guelman, S.,Wang, X.,Yang, J.,Phan, M.M.,Nguyen, V.,Chung, S.,Yu, C.,Tinianow, J.,Waaijer, S.J.H.,De Crespigny, A.,Marik, J.,Boswell, C.A.,Zabka, T.,Staflin, K.,Williams, S.P.
Preclinical development of ZED8, an 89 Zr immuno-PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.
Eur J Nucl Med Mol Imaging, 50:287-301, 2023
Cited by
PubMed Abstract: ZED8 is a novel monovalent antibody labeled with zirconium-89 for the molecular imaging of CD8. This work describes nonclinical studies performed in part to provide rationale for and to inform expectations in the early clinical development of ZED8, such as in the studies outlined in clinical trial registry NCT04029181 [1].
PubMed: 36271158
DOI: 10.1007/s00259-022-05968-6
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.6 Å)
Structure validation

238268

数据于2025-07-02公开中

PDB statisticsPDBj update infoContact PDBjnumon